Iraq ’sought nerve gas antidote’

Wednesday, 13 November, 2002, 11:54 GMT Iraq 'sought nerve gas antidote'
The US says Iraq must comply or face military action
State Department officials in Washington say Iraq has been trying to import large amounts of atropine, a drug that can be used to counter the effects of nerve gas.

They say the move may indicate that Iraq is preparing to use nerve gas if it comes under attack from the United States, and wants to be able to protect its own troops or civilians from the effects of the agent.

.instructionsheader{ font-family: verdana,arial; color: #666633; font-size: 11px; text-decoration:none; font-weight:bold;} .instructions{ font-family: verdana,arial; color: #000000; font-size: 11px; text-decoration:none;} <!– A.headsummary:link{ font-family : Verdana, Arial, Helvetica, sans-serif; font-size: 11px; color: #333366;} A.headsummary:hover{ font-family : Verdana, Arial, Helvetica, sans-serif; font-size: 11px; color: #CC3300;} A.headsummary:active{ font-family : Verdana, Arial, Helvetica, sans-serif; font-size: 11px; color: #333366;} A.headsummary:visited{ font-family : Verdana, Arial, Helvetica, sans-serif; font-size: 11px; color: #333366;} .inctext{font-family : Verdana, Arial, Helvetica, sans-serif;font-size: 11px;} //–>

A senior State Department official said Turkey had reported the order to the United Nations for investigation, and that the US Government was also looking into it.

There has been no official comment from the Turkish Government.

Disinformation?

US Secretary of State Colin Powell said he thought Iraq might be trying to scare Washington, which is still waiting to hear whether Saddam Hussein will accept a UN resolution requiring the return of weapons inspectors.

"Maybe it was a threat or some effort at disinformation, I don't know," said Mr Powell. "I don't want to say what they intended."

The US says Iraq tried to order 1.25 million doses of atropine from Turkey, but the vast size of the order raised suspicions.

Mr Powell said it was not clear if Iraq had managed to acquire any deliveries of the drug, which is not subject to the trade embargo on the country enforced by the UN.

Iraq did possess nerve agents at the time of the Gulf War a decade ago but Saddam Hussein was successfully deterred from using them.

The BBC's State Department correspondent, Jon Leyne says the fear is that if there is a war in which the Iraqi leader's very survival is at stake, this time he may have no reason to hold back.

Deadline looms

The US revelations came shortly after Iraq's parliament unanimously rejected the new United Nations resolution which requires Baghdad to allow complete access to all suspected weapons' site.

The final decision on whether to allow the inspectors back in however lies with Saddam Hussein.

He has until Friday to make up his mind. If he does not accept the terms, he faces the prospect of military action.

President George W Bush said on Tuesday the time for negotiations was over and he repeated that if Saddam Hussein did not act, the US would.

"There's no more time," he said. "There is a zero tolerance policy now. The last 11 years have been a period of time when this guy (Saddam) tried to deceive the world and we're through with it."

US Defence Secretary Donald Rumsfeld said the Iraqi leader had no intention of disarming and was already busy hiding his weapons of mass destruction. See also:

12 Nov 02 | Middle EastIraq parliament spurns inspectors
10 Nov 02 | Middle EastIraqis 'resigned to US attack'
10 Sep 02 | Middle EastSaddam's rival sons
12 Nov 02 | BusinessOil price rises on Iraqi vote
12 Nov 02 | Middle EastIraq 'stockpiled' nerve gas antidote
13 Nov 02 | Media reportsArab press debates Iraqi dilemma
13 Nov 02 | HealthQ&A: Nerve gas antidote
Internet links:

United NationsIraqi Presidency
The BBC is not responsible for the content of external internet sites
Top Middle East stories now:

US draws up second Iraq resolution
Mid-East peace moves urged
Saudis launch first al-Qaeda trial
Palestinian gas mask appeal dismissed
Kuwait protests over Iraq statement
Polio campaign launched in Iraq
Iran academic sent back to death court
Jerusalem gets ultra-Orthodox mayor
Links to more Middle East stories are at the foot of the page.

This is a part of article Iraq ’sought nerve gas antidote’ Taken from "Atropisol - Atropine Information" Information Blog

Go Digital 2002 archive

Thursday, 2 January, 2003, 16:07 GMT Go Digital 2002 archive
Here is your chance to watch an edition of Go Digital from 2002. Click on the links below to chose the program of your choice.

• Click here to watch programmes from 2001.

30 December - All the best from this year's Go Digital, including looking at the technology that changed 2002.
  56k modems

23 December - The technology behind the Beagle 2 robot destined for Mars and the music software that adapts to your mood.
  56k modems

16 December - Why mobile phones are going to be easier to recycle and how al-Qaeda uses the web to spread its propaganda.
  56k modems

9 December - An insight into the websites blocked by China and we look at one of the world's most powerful supercomputers, yours to own for just $2.5m.
  56k modems

2 December - How China is getting tough with the internet, using mobile phones to keep tabs on your health and your own personal rover robot.
  56k modems

25 November - Schools in Namibia turn their backs on Microsoft and the row over a website in Greece about the treatment of conscripts.
  56k modems

18 November - The school e-mail that travelled around the world and why women in Tanzania are catching the online bug. (Apologies for the lack of sound for the first two minutes)
  56k modems

11 November - Silk Road treasures united on the web, virtual exhibits bring the past to life and the environmental cost of making a microchip.
  56k modems

4 November - Going online in Singapore, how digital images could change many elements of design and teaching and the latest on the Simputer.
  56k modems

28 October - Pupils in Bangladesh discover the web and how telecentres in Senegal are offering opportunities for further education.
  56k modems

21 October - We look at ways of using technology to improve the health and welfare of people in Bangladesh and Senegal.
  56k modems

14 October - Hear how Senegal's militant Radio Oxyjeune is changing listeners' lives and how Bangladeshi people keep in touch with relatives overseas.
  56k modems

7 October - How village women in Bangladesh and Senegal are using mobiles to run thriving businesses and plans to create a software industry in Bangladesh.
  56k modems

30 September - Using technology to track bird movements, the future of the internet and how satellite technology is being used in developing countries.
  56k modems

23 September - How Bon Jovi is fighting music piracy, saving Tibet's heritage digitally and receiving medical updates on your mobile. (Apologies for the lack of sound for the first five minutes)
  56k modems

16 September - The CD-Rom helping farmers fight crop pests, the world of online gaming and how your voiceprint could replace your password.
  56k modems

9 September - The impact of September 11 on privacy, Greek gamers fight ban and how computer games are changing.
  56k modems

2 September - How computer games are getting more intelligent, having your say on the environment through the web and how robots are becoming more organic.
  56k modems

26 August - How computer programs are helping us speak in foreign languages such as Hindi and Croatian, and net pioneer Esther Dyson on making the internet more democratic.
  56k modems

19 August - How better computers are helping us hunt aliens, the row over Linux and the wedding photographer who is a robot.
  56k modems

12 August - Using satellite technology to track children, a portable ultrasound scanner and magnetic chips promise faster computers.
  56k modems

5 August - Recycling discarded mobile phones, the perils of e-mail and turning hi-tech into high art.
  56k modems

29 July - The youth clubs helping children learn about computers, the websites blocked by Saudi Arabia and ensuring secure credit card transactions.
  14k modems

22 July - The computer that is helping to fight obesity, getting the internet for free and the latest in digital animation.
  56k modems

15 July - Delivering the internet to India's villages, Canada's Inuit people take to the web and the challenges in setting up a news website in Urdu.
  56k modems

8 July - Why China is tightening controls on the internet, the cyber-rebels based at sea and how your eye could replace your computer mouse.
  56k modems

1 July - The website in Argentina where a click means a meal and Icann's boss Stuart Lynn on changes to the organisation that oversees the running of the net.
  56k modems

24 June - An assessment of how the net "snooping" laws in the UK were reined back and a look at the future of digital actors.
  56k modems

17 June - Iranian women speak out on the web, how scientists are packing more information into smaller devices and what you computer desktop says about you.
  56k modems

10 June - China's plans to limit radiation from mobile phones, archiving old Scottish dialects on the internet and the technology behind this year's Commonwealth Games.
  56k modems

3 June - A World Cup special, looking at who controls what football you can see on the web, the robots vying to be world champions and the computer simulation predicting a Latin victory.
  56k modems

27 May - Tight new controls on the internet in Turkey, putting old school friends back in touch with each other and why technology is good for your social life.
  56k modems

20 May - How technology can unleash a child's imagination, plans to bridge the digital divide and how computing has changed over the past 20 years.
  56k modems

13 May - Pakistan's ambitious plans for a virtual university, the video game celebrating 40 years of gaming and how technology is changing the way we watch TV.
  56k modems

6 May - Palestinian websites disrupted by the violence in the Middle East, the video game designed to help anxiety disorders and how secure is your computer password?
  56k modems

29 April - How to keep your computer safe from hackers, India's ethical hacker and the digital special effects for the forthcoming film, Spider-Man.
  56k modems

22 April - How the internet has united former foes in Kosovo, the promise of touch technology and rapper Chuck D on why musicians should embrace digital music.
  56k modems

15 April - Musical toys teach youngsters about music, Hong Kong prepares for smart ID cards and the many uses for Apple's iPod digital music player.
  56k modems

8 April - Bill Clinton on how technology can fight terror, training Nigeria's youth in computer skills and the robo-reporter destined for Afghanistan.
  56k modems

1 April - Giving old computers a new lease of life in Africa, the pioneer of free software speaks out and the virtual music studio changing the way the recording industry works.
  56k modems

25 March - Child soldiers in Sierra to swap their guns for computers, wearable computers give disabled children a voice and what to do if you are addicted to the internet.
  56k modems

18 March - In this special edition looking at the challenges posed by digital music, we talk to a music pirate, examine Apple's iPod music player and quiz veteran producer Steve Levine about the future of music
  56k modems

11 March - How digital imagery is helping preserve artworks, the smart credit card to fight fraud and what broadband can do for you
  56k modems

4 March - How the sound tracks of games are getting more polished, the family who wants to have chips implanted and how to cope with web rage
  56k modems

25 February - The digital camera chip challenging traditional film, the hi-tech airships bringing mobile phone networks to the world and sealcams reveal secrets of the underwater world.
  56k modems

18 February - Mobile phones come to Afghanistan, how technology can help industries in the developing world and why the web can undermine your concentration.
  56k modems

11 February - Watching you while you surf, how video games are getting smarter and why people in Ireland refused to embrace new technology.
  56k modems

4 February - How telemedicine is helping mental patients in Australia, broadcasting the internet on the radio and how digital technology could help Olympic athletes win gold.
  56k modems

28 January - The home with the internet everywhere, when screensavers are a crime and using virtual reality to revisit Northern Ireland's Bloody Sunday.
  56k modems

21 January - A special edition on the hottest technologies to emerge at the Consumer Electronics Show, including the wearable computer for commuters, the wind-up charger for mobile phones and the smart home.
  56k modems

14 January - Asia's plans to link together hi-tech cities, a review of Apple's new iMac and behind the scenes as Mali prepares to host the African Cup of Nations.
  56k modems

7 January - How New Zealand is bring the elderly online, using virtual reality to tackle real-life problems and a look at some of the latest gadgets.
  56k modems

The programme is broadcast every week on the BBC World Service radio on Tuesday, Wednesday and Thursday. Local times vary.

This is a part of article Go Digital 2002 archive Taken from "Buy Buspar Buspirone" Information Blog

Augmentation/Combination Therapy in the STAR*D Trial

More: Medscape Perspectives on the American Psychiatric Association (APA) 2007 Annual MeetingSelection from: Pharmacologic Management of Treatment-Refractory Depression

Augmentation/Combination Therapy in the STAR*D Trial  CME/CE

Maurizio Fava, MD   Jennifer M. Covino, MPA   Disclosures

According to the Global Burden of Disease Study,[1] the public health implications of depression are vast; depression currently ranks as the 4th leading global disease burden and is projected to rise to the number 2 disease burden worldwide in 2020, second only to ischemic heart disease. Antidepressants are the mainstay of treatment for depression and depressive episodes; however, these treatments are often incomplete or inadequate. Indeed, approximately 2 million individuals in the United States will experience an inadequate response to treatment for depression during their lives.[2] Clinicians are therefore presented with the challenge of tailoring and adjusting treatments to the individual patient, as they work to find the best matched treatment to not only achieve, but also to sustain remission.

In an effort to provide relief to those suffering from such a debilitating illness, clinicians rely on a variety of augmentation and combination strategies. New research presented at the 160th Annual Meeting of the American Psychiatric Association in San Diego, California, examined many of these strategies with a major focus on the recent Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study.

Treatment-Refractory Depression and STAR*D

The definition of treatment-refractory depression (TRD) is the subject of debate. TRD is described variously as depression that does not remit with 1 or more adequate antidepressant trials,[3] or 2 or more acute treatment trials;[4] or failure to respond to 4 or more different antidepressant approaches including augmentation, combination, and electroconvulsive therapy (ECT).[5] TRD can be related to a variety of factors including poor efficacy, intolerable adverse effects, drug-drug interactions, comorbid medical illness, and nonadherence.[6]

When considering the treatment of depression, one important limiting factor is the paucity of literature surrounding TRD, which is further complicated because published studies often have excluded many of the 'sickest' patients, precisely the patients that most clinicians face in daily practice.[7] The STAR*D study was designed to conduct research that mirrored clinical practice, providing options to patients seeking treatments as they moved through each step of the trial.[8]

The STAR*D project enrolled 4041 patients with a broad range of symptoms and severity from 25 participating sites.[9] The study involved 4 possible 'steps' for treatment, and any patient who failed to meet remission criteria at each step was then asked to move to the next level.[10] Of note, the study revealed what is often seen in clinical practice; patients tended to choose an option based on their experiences with the initial antidepressant. If they experienced a partial response, they chose augmentation; if they were not responding, they preferred to switch, and so forth.Level 1: The first treatment level consisted of citalopram at maximally tolerated doses titrated as quickly as could be achieved (dropout rate was approximately 8%). Patients were encouraged to continue the treatment for up to 12 weeks. A total of 3671 patients participated in level 1 treatment with citalopram monotherapy.

Level 2: After 12 weeks, if patients failed to reach remission in level 1, they were randomized to the next level, depending on their preference to switch to a different medication (bupropion SR, N = 239; sertraline, N = 238; or venlafaxine XR, N = 250), switch to cognitive therapy (N = 62), augment citalopram with another medication (bupropion SR, N = 279; or buspirone, N = 286), or augment citalopram with cognitive therapy (N = 85). Participants who chose to switch to or augment with cognitive therapy were randomized separately.

Level 3: Participants who did not achieve remission after 12 weeks in level 2 were randomized to: switch to mirtazapine (N = 110); switch to nortriptyline (N = 116); or augment level 2 treatment with lithium (N = 63) or thyroid medication (N = 70).

Level 4: To remain in the study, patients who did not achieve remission after 12 weeks in level 3 were required to switch to the nonhydrazine monoamine oxidase inhibitor, tranylcypromine (N = 55); or switch to a combination of venlafaxine XR and mirtazapine (N = 50).

This study used 3 methods of evaluation: HAM-D scales administered over the phone (single-blind) by those who did not know which treatment a patient was receiving; interactive voice response (IVR) system and self-reports with pencil; and paper Quick Inventory of Depressive Symptoms — self-report (QIDS) scale.

Augmentation and Combination in STAR*D

For purposes of this report, we will focus on the pharmacologic augmentation and combination results of those who remained on pharmacotherapy throughout the study.Level 2: Augmentation With Bupropion SR and Buspirone

Alan Schatzberg, MD, Professor of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California,[11] discussed some of the advantages and disadvantages of both bupropion SR and buspirone augmentation. First, Dr. Schatzberg noted that one advantage of bupropion SR is that it may assist with the treatment of SSRI-induced sexual dysfunction; but a disadvantage is that we lack double-blind placebo-controlled trials of bupropion, and the metabolism of this agent can inhibit metabolism of some SSRIs. By contrast, buspirone monotherapy has been studied in 5 double-blind trials with the composite data set showing efficacy; moreover, several open label trials have shown buspirone to be a useful augmentation agent. The largest disadvantage of buspirone augmentation is that this agent has generally failed in double-blind studies of refractory depression.

Dr. Schatzberg, specifically discussed the resulting data from the STAR*D level 2 treatment arm that involved augmentation with sustained release bupropion (up to 400 mg/day; N = 279) or buspirone (up to 60 mg/day; N = 286). Remission rates based on the Hamilton Rating Scale for Depression (HRSD-17) were 29.7% for bupropion and 30.1% for buspirone. Remission rates based on QIDS-SR-16 were 39.0% for bupropion and 32.9% for buspirone.

Trivedi and colleagues[12] evaluated the use of bupropion and buspirone in the STAR*D study and found that bupropion led to greater reduction in the number and severity of symptoms, with fewer side effects and adverse events. In this analysis, the group that received sustained-release bupropion demonstrated greater reductions in QIDS-SR-16 scores than buspirone (25.3% vs 17.1% from baseline, P < .04); a lower QIDS-SR-16 score (8.0 vs 9.1, P < .02); and lower dropout rates related to intolerance (12.5% vs 20.6%, P < .009).Level 3: Lithium and Triiodothyronine Augmentation

Dr. Schatzberg also discussed lithium and thyroid augmentation.[11] He began by summarizing the highlights of the literature on lithium. At least 50 trials have used lithium as an augmentation agent and yielded mostly positive results; these studies have most frequently used lithium in conjunction with tricyclic antidepressants; levels of 0.4 mg to 0.6 mg are often effective; there is a low therapeutic index; and patients sometimes require monitoring of thyroid and renal function, an additional burden. With regard to augmentation with thyroid hormone, there have been at least 25 mostly positive trials; studies have indicated that thyroid augmentation may help with energy and weight; it is well tolerated when compared with lithium; it may work less well in men; it can cause bone demineralization; and thyroid levels must be monitored, adding a burden to patients.

Timothy Petersen, PhD,[13] Assistant Professor of Psychiatry at Harvard Medical School in Cambridge, Massachusetts, summarized the level 3 augmentation options of either lithium (N = 69) or T3 (N = 73). Based on HRSD-17, remission rates were 15.9% for lithium and 24.7% for T3; based on the QIDS-SR-16, remission rates were 13.2% for lithium and 24.7% for T3. These results indicate that failure to achieve response or remission at level 2 (bupropion SR or buspirone) predicts lower response/remission rates at level 3. Despite the low numbers, a limited number of patients will experience benefit with lithium or T3, indicating that using all available options is sometimes necessary because we currently cannot predict who might respond to which medication and/or augmentation strategy.

STAR*D Augmentation/Combination Summary

Dr. Petersen[13] concluded that when one looks at the STAR*D, data pertaining to remission based on the augmentation/combination trials (levels 2-4), one sees that remission rates drop from 35% at level 2 to 19% at level 3 and 16% at level 4, which, according to Dr. Petersen, indicates that failure to achieve remission with one agent at level 1 does not substantially reduce the chances of remission with a next-step augmentation trial. However, failure to achieve remission with 2 consecutive treatments is associated with very low remission rates with subsequent treatments. Dr. Shatzberg[11] concluded that although remission rates were relatively low in all phases, buspirone, bupropion SR, and thyroid appear to offer considerable benefit. He also noted that low remission rates across all trials indicate that many patients still require additional treatment.

The STAR*D trial was designed to mirror the methods clinicians use in practice, and the results of this large multicenter trial mirror what many clinicians have seen for years — challenges in understanding and deciding upon the best treatment options for the individual patient in an effort to achieve and maintain response with the ultimate goal of remission. STAR*D shows that, as additional augmentation/combination strategies are used, the response and remission rates of patients decreased; however, a small population of patients did respond and/or remit with these additional strategies. Thus, clinicians must use an array of pharmacotherapies as they work to alleviate depression in patients through what becomes an individualized 'trial and error' mechanism. Of importance, the STAR*D study also highlights that despite our best efforts, and given our current treatment options, a vast number of individuals remain without relief from their depression. Clearly further research is warranted as we work to understand the underlying causes of depression and best treatment modalities for individuals suffering from this illness.

Supported by an independent educational grant from Bristol-Myers Squibb

References

References

Murray CJL, Lopez AD. Alternate projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349:1498-1504. AbstractNemeroff CB. Caring for our most challenging patients with depression: an interactive forum on novel treatments. Program and Abstracts of the American Psychiatric Association 160th Annual Meeting; May 19-24, 2007; San Diego, California. Abstract 17B.Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am. 1996;19:179-200. AbstractRush A. Treatments after the first two steps including follow-up: level 3 and level 4. Program and Abstracts of the American Psychiatric Association 160th Annual Meeting; May 19-24, 2007; San Diego, California. Abstract 21D.Nemeroff CB. Caring for our most challenging patients with depression: an interactive forum on novel treatments. Program and Abstracts of the American Psychiatric Association 160th Annual Meeting; May 19-24, 2007; San Diego, California. Abstract 17B.Perlis RH. Do antidepressants work in the real world and for whom? Program and Abstracts of the American Psychiatric Association 160th Annual Meeting; May 19-24, 2007; San Diego, California. Abstract 4B.Alpert JE. Improving depression treatments: bridging the gap between clinical trials and community practice. Program and Abstracts of the American Psychiatric Association 160th Annual Meeting; May 19-24, 2007; San Diego, California. Abstract 28A.Fava M. Insights from STAR*D: are our patients' needs being met? Program and Abstracts of the American Psychiatric Association 160th Annual Meeting; May 19-24, 2007; San Diego, California. Abstract 4A.Nierenberg AA. A critique of current and future treatments for difficult-to-treat depression. Program and abstracts of the American Psychiatric Association 158th Annual Meeting; May 21-26, 2005; Atlanta, Georgia. Abstract 86C.Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905-1917. AbstractSchatzberg AF. Augmentation and combination strategies in treatment resistant depression. Program and Abstracts of the American Psychiatric Association 160th Annual Meeting; May 19-24, 2007; San Diego, California. Abstract 4E.Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354:1243-1252. AbstractPetersen T. The sequenced treatment alternatives to relieve depression (STAR*D) study: lessons learned. Program and Abstracts of the American Psychiatric Association 160th Annual Meeting; May 19-24, 2007; San Diego, California. Abstract 28F.
  
This is a part of article Augmentation/Combination Therapy in the STAR*D Trial Taken from "Buy Buspar Buspirone" Information Blog

Management of OCD in Children and Adolescents

Management of OCD in Children and Adolescents

from Drugs & Therapy Perspectives

Diagnosis Can Be Tricky

There are frequent and well known comorbid conditions that accompany or precede OCD in children which can complicate diagnosis.[1] The most frequent of these are:

depression

separation anxiety disorder

generalised anxiety disorder (GAD)

tic disorders

eating disorders.

In addition, there are a number of other conditions which, although they can be diagnosed along with OCD, should be differentiated from the specific manifestations of OCD (see table 1).

This is a part of article Management of OCD in Children and Adolescents Taken from "Buy Buspar Buspirone" Information Blog

Newly Diagnosed Human Immunodeficiency Virus

Newly Diagnosed Human Immunodeficiency Virus

from Southern Medical Journal

Case Report

A 38-year-old Hispanic man with no significant medical history came to the emergency room with complaints of a "10/10" retroorbital headache, photophobia, fevers, and a rash. The patient reported that he was in his usual state of good health until 2 weeks before admission, when he was placed on a 14-day course of TMP-SMZ (Bactrim DS), loratadine (Claritin), and acetaminophen for symptoms of cough, rhinorrhea, and sinus congestion. Despite treatment, symptoms continued. Myalgias, intermittent chills, and subjective fevers developed 1 week before admission. Two days before admission, a diffuse "red rash" and conjunctivitis developed. Treatment with sulfacetamide ophthalmic solution was started the evening before admission. Eye pain intensified after administration of the ophthalmic solution, and the patient had a headache that prompted the emergency room visit.

The patient denied nausea, vomiting, diarrhea, or weight loss. He denied any recent travel, unusual food, or animal exposure and reported that one coworker was ill with pneumonia. He reported being heterosexual and appropriately using a condom during his last sexual encounter 7 months earlier. He denied history of blood transfusion; use of tobacco, alcohol, or intravenous drugs; or homosexual activity. There was no history of medication allergies or previous exposure to TMP-SMZ.

On examination, the patient appeared thin, ill, and in moderate distress. Vital signs were blood pressure 95/54 mm Hg, heart rate 118/min, respiratory rate 22/min, and temperature 101.7°F. Physical examination was notable for nonicteric sclera, marked bilateral conjunctival injection, photophobia, shoddy cervical adenopathy, and lack of meningeal signs. The oropharynx was erythematous without exudate, lesions, or ulcers. Cardiac and lung examinations were normal. There was a diffuse, nonblanching, erythematous, macular eruption over the torso with no evidence of target lesions. There was 1+ pretibial, pitting edema bilaterally. Laboratory values were white blood cell count of 5.1 x 109/L (53% segmented neutrophils, 39% band forms, 7% lymphocytes, and 1% monocytes), hemoglobin 149 g/L, hematocrit 43.7%, and platelets 249 x 109/L. Liver-associated enzyme levels were elevated, with alkaline phosphatase 131 U/L (normal, 38 to 126 U/L), aspartate aminotransferase 103 U/L (normal, 14 to 36 U/L), alanine aminotransferase 111 U/L (9 to 52 U/L), and total bilirubin 8.55 mmol/L. Lumbar puncture revealed clear, colorless fluid with negative Gram's stain, white blood cell count 22 x 109/L (97% lymphocytes, 2% segmented neutrophils, 1% monocytes), protein 0.74 g/L, and glucose 2.66 mmol/L. Serum glucose was 5.66 mmol/L. Electrolytes, prothrombin time, partial thromboplastin time, and urinalysis were normal. Computed tomography of the sinuses and a chest radiograph were unremarkable.

The patient was admitted to the hospital, sulfa-containing medications were discontinued, and intravenous (IV) piperacillin sodium-tazobactam sodium (Zosyn) and IV erythromycin were started, given the clinical picture consistent with sepsis. The infectious diseases and dermatology services were both consulted, and the patient's symptoms were thought to be consistent with those of a hypersensitivity reaction to sulfa drugs. During hospital day 1, he continued to have fevers up to 103°F, with persistent rash, myalgias, and headache. On the second hospital day, a capillary leak syndrome developed, manifested by pulmonary edema, a mild coagulopathy without bleeding, and peripheral edema. Oxygen and supportive measures were used. On hospital day 3, he was afebrile without headache, and the rash was resolving. All blood, urine, and cerebrospinal fluid cultures done on admission remained negative for organisms, and antibiotics were discontinued. He was monitored without recurrence of fever, coagulopathy resolved, liver enzymes normalized, and the chest's appearance on radiographs returned to normal. He was discharged on hospital day 6 in improved health.

After discharge, Lyme electroimmunofluorescence assay, hepatitis serologies, and fungal cultures remained negative. Enzyme-linked immunosorbent assay and Western blot done during hospitalization were positive for HIV, with HIV-1 RNA of 33,313 copies/mL. Initial CD4 count was 483 (21%). The patient was informed of his HIV status. He denied any identifiable risk factors for HIV infection. Treatment was initiated with lamivudine-zidovudine (Combivir) and nelfinavir mesylate. Six months after discharge, his viral load was below the detectable level with a CD4 count of 794 (25%).

This is a part of article Newly Diagnosed Human Immunodeficiency Virus Taken from "Claritin Loratadine 10Mg" Information Blog

Allergic Rhinitis and Asthma: The Link, The New ARIA Classificat

Leukotriene Receptor Antagonists in Allergic Rhinitis

Both histamine and cysteinyl leukotrienes are elevated in the nasal secretions of patients with allergic rhinitis. Whereas histamine induces some of the responses that typify allergic rhinitis (e.g. itching and sneezing), other mediators such as cysteinyl leukotrienes are 5000 times more potent than histamine in causing nasal congestion.

In a multicentre, double-blind trial in patients with spring seasonal allergic rhinitis, randomly assigned to once-daily montelukast (10 mg), loratadine (10 mg) or placebo, Meltzer et al..[22] demonstrated that both the daytime and nighttime nasal symptom scores were significantly (P<0.001) reduced with montelukast and loratadine compared with placebo. The quality of life was also improved with montelukast and loratadine versus placebo (P<0.005). In addition, after 2 weeks of treatment, peripheral blood eosinophil counts were significantly (P </=0.001) decreased with montelukast but not with loratadine or placebo.[21] A montelukast-induced reduction in airway eosinophilia was also reported in the sputum of patients with asthma. In another 2-week study.[22] the concomitant use of montelukast and loratadine improved the individual symptoms, composite scores and global evaluations, and rhinoconjunctivitis quality of life. Wilson et al..[23] studied the effects of an LTRA and antihistamine oral combination (montelukast plus cetirizine) in comparison with mometasone, an intranasal steroid. Intranasal steroids are known to be effective for all symptoms of allergic rhinitis. The study showed that the combination of montelukast plus cetirizine produced significant (P<0.05) improvements compared with placebo in the peak nasal expiratory flow rate, nasal oral index, nasal symptoms, nasal itch and blockage, eye symptoms and daily activity score. Importantly, there were no significant differences between mometasone and montelukast plus cetirizine. Furthermore, in a study by Price et al..[24] in patients with asthma and co-morbid allergic rhinitis, the use of montelukast with budesonide as a combination therapy was shown to be superior to doubling the dose of budesonide, both with or without the use of concomitant allergic rhinitis medications.

Therefore, oral drugs such as LTRAs that are effective for both rhinitis and asthma may be a good alternative for those patients who are not compliant with topical drugs. In fact, in the recent One Airway Survey.[8] treating both allergic rhinitis and asthma effectively was a concern raised by respondents to the survey. Almost three out of four patients (73%) responded that they found it difficult to treat both conditions effectively at the same time, and 85% noted concerns about using too many medications to treat the two conditions. The route of administration was also an important consideration among survey respondents, with nearly two-thirds (65%) reporting that they preferred to use oral medication rather than nasal sprays. Therapeutic strategies such as LTRAs thus represent a particular advance in therapy for the considerable numbers of patients with asthma and co-existing allergic rhinitis, and can increase patient compliance and improve the quality of life.

Reprint Address

Correspondence to Prof. Ruby Pawankar, MD, PhD, Department of Otolaryngology, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-Ku, Tokyo 113-8603, Japan Tel/fax: +81 48 597 2861; e-mail: Pawankar_Ruby/ent@nms.ac.jpAbbreviation Notes

ARIA, Allergic Rhinitis and its Impact on Asthma; ICS, inhaled corticosteroid; LTRA, leukotriene receptor antagonistPrevious PageSection 6 of 6Curr Opin Allergy Clin Immunol 4(1):1-4, 2004. © 2004 Lippincott Williams & Wilkins
This is a part of article Allergic Rhinitis and Asthma: The Link, The New ARIA Classificat Taken from "Claritin Loratadine 10Mg" Information Blog

Urinary Incontinence in the Elderly

Urinary Incontinence in the Elderly

from Southern Medical Journal

Key Points

Frail nursing home residents often have urinary incontinence that can be improved or cured.

There are four types of chronic incontinence: Detrusor overactiviey (urge) incontinence, stress incontinence, overflow incontinence, and functional incontinence.

Treatment is based on the type of incontinence, and may include muscle exercises, biofeedback, electric stimulation, behavioral treatments, various surgical interventions, and pharmacologic treatments, such as anticholinergic-antispasmodic agents and alpha-adrenergic antagonists.

Reprint Address
Reprint requests to Ivan Merkelj, MD, East Tennessee State University, PO Box 70429, Johnson City, TN 37614-0429.

Section 8 of 8
South Med J 94(10):952-957, 2001. © 2001 Southern Medical Association
This is a part of article Urinary Incontinence in the Elderly Taken from "Atropisol - Atropine Information" Information Blog

FDA Approves Oraquick HIV-1/2 Antibody Test, Follistim AQ Cartridge, Viewpoint CK System, and Chewable Zyrtec

Yael Waknine

March 25, 2004 — The U.S. Food and Drug Administration (FDA) recently approved an HIV test, a fertility device, a keratoplasty procedure, and a chewable antihistamine for children.

Oraquick Rapid HIV-1/2 Antibody Test for the Detection of HIV

OraSure Technology received FDA approval yesterday for its Oraquick Rapid HIV-1/2 Antibody test, which provides simultaneous detection of antibodies to both HIV-1 and HIV-2 in finger stick and venipuncture whole blood specimens.

The single rapid test for both strains may allow for broader detection, treatment, and prevention of HIV/AIDS. "This is particularly important in the higher prevalence urban areas here in the United States where HIV-2 infection is more likely to occur and in many foreign countries where HIV-2 testing is required as part of the normal testing regimen," says Mike Gausling, president and chief executive officer of OraSure, in a news release.

Follistim AQ Cartridge for Delivery of FSH

The Follistim AQ cartridge received FDA approval this week for use with the Follistim pen in self-administered, individualized dose injections of premixed follitropin beta, a follicle-stimulating hormone (FSH) made from recombinant DNA technology used in fertility treatments.

The Follistim AQ cartridge used with the pen is prescribed for women undergoing assisted reproductive treatments such as in vitro fertilization, and for the induction of ovulation to achieve pregnancy.

The cartridge, available in strengths of 300 IU and 600 IU, provides physicians with the flexibility to fine-tune individual drug protocols for patients. Self-injection is safe, and the accurate dosing delivers on average an 18% higher amount of follitropin beta compared with lyophilized preparations administered by a conventional syringe and needle, according to a news release from Organon, the maker of the cartridge.

"Fertility treatment can create anxiety for patients, in large part because they have to mix, measure, and inject the medicine themselves," Samuel Pang, MD, associate medical director of the Reproductive Science Center in Boston, Massachusetts and investigator in the Follistim clinical trials, says in the news release. "This innovative method of delivering FSH makes the process go smoothly, because the medication is already mixed and the patient just has to dial the correct dose. Also, the microneedle and small volume of injection may contribute to patient tolerability of the injection."

Viewpoint CK System for Presbyopia

The Viewpoint CK system for performing the NearVision conductive keratoplasty procedure was approved by the FDA this week for the temporary improvement of near vision due to emmetropic and hyperopic presbyopia. The system is made by Refractec.

Presbyopia, or loss of near vision, is an age-related condition affecting most people after age 40 years, and all people by age 51 years.

"Presbyopia is the one inescapable vision disorder that will eventually affect us all," says Daniel S. Durrie, MD, from the University of Kansas and medical monitor for the FDA clinical trial of presbyopia, in a company news release. "The frustration many people feel with the on-again, off-again annoyance of reading glasses cannot be overemphasized. NearVision is just what baby boomers have been waiting for to help them get rid of their reading glasses and safely see like they did when they were young."

Conductive keratoplasty is a safe, minimally invasive, non-laser procedure for patients who now require reading glasses to compensate for fading near vision. The procedure is painless and takes about three minutes in an outpatient setting. The procedure improves near vision without compromising the patient's binocular distance vision.

The procedure is performed using a small probe, thinner than a strand of human hair, that releases radio waves. The probe is applied in a circular motion on the outer cornea to shrink small areas of collagen, creating a constrictive band that increases the overall curvature of the cornea and brings near vision back into focus.

The FDA based its approval on clinical trial data collected at one year after conductive keratoplasty. At that time, 98% of patients could see J5 (newspaper-size print) with the corrected eye, while 87% of patients could see 20/20 in the distance and also read J3 (phonebook-size print).

Zyrtec Chewable for Seasonal and Chronic Allergic Rhinitis

A new chewable formulation of cetirizine hydrochloride (Zyrtec) was approved by the FDA this month for the treatment of seasonal and chronic allergic rhinitis and chronic idiopathic urticaria in children aged 2 years and older. The new formulation is made by Pfizer.

The chewable formulation of cetirizine is aimed at children aged six to 12 years who are too young to swallow tablets.

The grape-flavored tablets are taken once daily with or without food or water, and are available in 5-mg and 10-mg doses for flexibility in age-related dosing.

"This new chewable formulation provides more convenience and flexibility for a trusted antihistamine," says Gail Shapiro, MD, in a company news release. Dr. Shapiro is an allergist at the University of Washington School of Medicine in St. Louis, Missouri, and past president of the American Academy of Allergy, Asthma and Immunology.

Reviewed by Charlotte Grayson, MD

Yael Waknine is a freelance writer for Medscape.
This is a part of article FDA Approves Oraquick HIV-1/2 Antibody Test, Follistim AQ Cartridge, Viewpoint CK System, and Chewable Zyrtec Taken from "Claritin Loratadine 10Mg" Information Blog

Antidotes for acute cardenolide (cardiac glycoside) poisoning

Entry

Cardenolides are naturally occurring histrion toxins which act primarily on the eye.
While kill with the herbaceous plant cardenolides (digoxin and digitoxin) are reported worldwide, cardiotoxicity from other cardenolides such as the yellow oleander are also a discipline job, with tens of thousands of cases of killing each year in Confederate States of America Asia.
Because cardenolides from these plants are structurally similar, acute poisonings are managed using similar treatments.
The performance of these treatments is of curiosity, particularly in the context of use of cost since most poisonings occur in developing countries where resources are very limited.Objectives

To determine the efficacy of antidotes for the direction of acute cardenolide putting to death, in constituent atropine, isoprenaline (isoproterenol), multiple – dose activated oxford gray (MDAC), fructose – 1,6 – diphosphate, sodium bicarbonate, magnesium, phenytoin and anti – digoxin Fab antitoxin.Scrutiny military science

We searched MEDLINE, EMBASE, the Controlled Trials Tone of the Cochrane Cooperation, Course Cognizance in Clinical Toxicology, Info Trac, www.google.com.au, and Discipline Credit Ordered series of studies identified by the previous searches.
We manually searched the bibliographies of identified articles and personally contacted experts in the orbit.Assortment criteria

Randomised controlled trials where antidotes were administered to patients with acute symptomatic cardenolide killing were identified.Data compendium and style

We independently extracted data on domain pattern, including the acting of randomisation, associate characteristics, type of engagement and outcomes from each domain.
We independently assessed methodological dimension of the included studies.
A pooled criticism was not appropriate.Main results

Two randomised controlled trials were identified, both were conducted in patients with yellow oleander kill.
One attempt investigated the consequence of MDAC on rate, the someone risk (RR) was 0.31 (95% authority separation (CI) 0.12 to 0.83) indicating a beneficial signification.
The second gear knowledge domain found a beneficial essence of anti – digoxin Fab antitoxin on the comportment of cardiac dysrhythmias at two period of time post – administration; the RR was 0.60 (95% CI 0.44 to 0.81).
Other benefits were also noted in both studies and serious adverse effects were minimal.
Studies assessing the significance of antidotes on other cardenolides were not identified.
One ongoing knowledge base investigating the activated wood coal for acute yellow oleander self – intoxication was also identified.Authors’ conclusions

There is some indication to suggest that MDAC and anti – digoxin Fab antitoxin may be effective treatments for yellow oleander killing.
However, the efficacy and indications of these interventions for the care of acute herb physiological condition is uncertain due to the lack of good tone controlled clinical trials.
Given pharmacokinetic differences between soul cardenolides, the upshot of antidotes administered to patients with yellow oleander killing cannot be readily translated to those of other cardenolides.
Unfortunately cost limits the use of antidotes such as anti – digoxin Fab antitoxin in developing countries where cardenolide poisonings are frequent. More research is required using relatively cheap antidotes which may also be effective.
This is a part of article Antidotes for acute cardenolide (cardiac glycoside) poisoning Taken from "Atropisol - Atropine Information" Information Blog

IFIS and Cataract Surgery

Tamsulosin has been used as an businessperson to improve urinary symptoms, often in men with an enlarged prostate.
It acts as an alpha-1 antagonistic muscle and inhibits smooth bully condensation within the urinary vesica and prostate.
Intraoperative floppy iris composite (IFIS), a side event of tamsulosin, was noted in 2005. This symptom is characterized by poor pupillary discourse, prolapse of the iris, intraoperative billowing of the iris, and grownup pupillary inborn reflex. Action and withering of the iris drug brawn may be responsible for these perioperative findings, although histologic ratification is lacking.

Intraoperative complications have been noted as a effect of IFIS, including iris health problem with sequent weakening and separation of the tush ejection seat with vitreous loss. Furthermore, commonly used techniques for eye disease medical science in patients with body part pupils have largely been ineffective in patients with IFIS.

Prospective Multicenter Judgement of Falls Operation in Patients Taking Tamsulosin (Flomax)

The authors of this prospective observational case connexion reviewed 135 men (167 eyes) who had a continuum of tamsulosin use and underwent phacoemulsification.
The inclemency of IFIS was noted as mild in 17%, moderate in 30%, and severe in 43% of patients (no IFIS was noted in 10%).
One of 4 techniques was used in the organisation of IFIS: preoperative topical 1% atropine, iris retractors, spring chicken single-valued function ring, and the use of a viscoadaptive ophthalmic viscosurgical gimmick with reduced fluidic parameters.
The selection was left up to the operating surgeon, and some used more than one skillfulness.
When iris retractors or schoolchild discourse rings were used, no other method acting proved necessary.
Topical atropine was used as the sole performing for 8 eyes, and in 11 others additional techniques were used.
Using these techniques, the rate of bottom abridgment falling out and vitreous loss was 0.6% (1 in 167 eyes).
Tamsulosin was discontinued (1-8 weeks preoperatively) for 32 eyes, and no significant divergence was seen in IFIS asperity.Gossip

The complications of IFIS have sparked changes in the perioperative establishment of patients undergoing waterfall operating theatre.
These intraoperative findings have also prompted honorable mention of an adverse ocular physical phenomenon in those considering eye disease surgical process in recent telecom equipment advertisements for tamsulosin.
The authors pointed out that IFIS is not medicament to tamsulosin and may occur with other alpha-1 antagonists, although it appears to be less severe.
It is not country when in the course of instruction of therapy with an alpha-1 resister that a participant role may be at risk for IFIS, but some reports suggest that this complex may occur within weeks of starting tamsulosin.

The findings of this work emphasize both the value of obtaining a arts of tamsulosin use (including prior use — IFIS has been reported geezerhood after discontinuation of tamsulosin) and of experienced surgeons.
IFIS was anticipated in this musical composition, and these patients did well, with a lower hindrance rate than that reported in prior broadcast of patients using tamsulosin whose IFIS was not necessarily suspected.
Moreover, the 10 centers involved in this piece had 15 experienced waterfall surgeons who would have a very low expected rate of intraoperative complications.
This is a part of article IFIS and Cataract Surgery Taken from "Atropisol - Atropine Information" Information Blog

Predicting Late Cardiac Events in Vascular Patients

Predicting Late Cardiac Events in Vascular Patients

Methods

Affected role Integer

The sketch radical was composed of 233 consecutive patients referred for DSE before a vascular activity between 1992 and 1995.
Clinical data regarding the past cardiac chronicle, cardiac risk factors, and medical therapy were obtained prospectively.
Preoperative clinical risk was scored on the constituent of cardiopathy, prior infarction or Q waves, diabetes, and gist insolvency.

Dobutamine Prosody Test Etiquette

After at least 4 hour of fasting, line echocardiographic images were obtained in the left lateral decubitus relation.
Resting images were obtained in parasternal long- and short-axis, and apical 4- and 2-chamber views.
Dobutamine extraction was started at 5 mg/kg/min and increased every 3 minutes to 10, 20, 30, and a upper limit of 40 mg/kg/min.
Atropine (maximum of 2 mg) and handgrip were used in patients who failed to achieve at least 85% of boundary predicted suspicion rate after the peak dose of dobutamine.
Echocardiographic images were obtained at each dose physical process and digitized on-line (ImageVue, Eastman Kodak Wellbeing Imaging) with electrocardiographic gating.
Images were also stored on taping.
Continuous electrocardiographic monitoring was done using a 3-channel scheme, and a 12-lead electrocardiogram (ECG) was obtained at the first of each travelling or with symptoms.
The test was terminated at the end of the communications protocol (40 mg/kg/min dobutamine, 2 mg atropine) or if there was severe ischemia or other intolerable symptoms or side effects (most commonly hypotension, severe hypertension, or arrhythmias).

Echocardiographic Abstract thought

Digitized quad-screen and videotaped images were analyzed by 2 experienced observers blinded to the clinical data.
By use of a 16-segment kind, regional wall apparent movement was scored qualitatively at rest, low-dose, and peak accent.
Myocardial ischemia was defined as a new or declension wall gesture misdeed provoked by pharmacologic emphasis.
A biphasic answer, with transformation at low doses of dobutamine and then subsequent deterioration of wall motility at higher doses, was also considered to represent an ischemic consequence.
Scar was identified if a myocardial portion showed no information of ischemia but had a resting wall natural event misdeed.
A “normal” speech act was identified in the seizure of rest or stress-induced regional wall change abnormalities but included patients with global left ventricular dysfunction if this was not focal.
Left ventricular expulsion rational number (EF) was classified as normal (>=55%), mild (EF 40% to 54%), moderate (EF 30% to 39%), or severe (EF <30%).

Patient role Finish Infinitesimal calculus

Patients were prospectively observed to the time of infirmary electric arc to identify perioperative cardiac events.
Late events were identified by health facility legal proceeding or telecommunication follow-up if this was not possibility.
The predetermined whole end linear unit was composed of cardiac last, myocardial infarction, and unstable or grownup cardiopathy requiring revascularization.
Cardiac organic phenomenon was defined as a decease from myocardial infarction, congestive gist unfortunate person, fatal arrhythmia, or sudden expiry.
Myocardial infarction was defined with the usual clinical, enzymatic, and ECG criteria.
Unstable heart disease was defined as an accelerated exemplar of article of furniture pain requiring medical institution accession because of increased cardinal, longer time period, or increased refractoriness of pain to course therapy.

Statistical Investigating

Differences in continuous variables were compared with Student’s t test or expressive style of variant, whereas differences in categoric variables were compared with the chi-square abstract thought.
The null conception was rejected when there was <5% luck of a resultant living thing from hazard alone.
Kaplan-Meier life curves were used to transport cumulative event-free endurance from the time of operating theater.
The log-rank statistic was used to compare the differences between the life curves.
This is a part of article Predicting Late Cardiac Events in Vascular Patients Taken from "Atropisol - Atropine Information" Information Blog

Danger drugs taken from ambulance

Dangerous drugs were stolen from an ambulance while crews were transaction with a patient role.

Family have been warned not to take the drugs, which were stolen along with medical equipment and a equipment transportation grouping.

The theft happened while the ambulance crews were in a law-makers in Bourneside Road, Addlestone, Equipage on Monday.

Officers said anyone who found the drugs should take precautions and hand them to police.

Appealing for witnesses, a police spokesman asked anyone who may have seen youths near the ambulance, or in the road, to lens system the causal agent.
This is a part of article Danger drugs taken from ambulance Taken from "Atropisol - Atropine Information" Information Blog

Bladder and Urinary Tract Prone to Drug-Induced Disorders

Urinary faculty can be either acute or chronic.
Acute urinary impermeableness is painful, often presenting as an crisis.
A more insidious onrush can lead to chronic urinary impermeability which may lead to renal nonstarter as a ending of increased stimulant urinary geographic region pressure sensation.

Antimuscarinics a Likely CauseAll drugs with antimuscarinic effects can origin or exacerbate urinary module as a consequence of luck of bag diminution, especially where there is pre-existing vesica discharge obstructer (see plateau 1).

Antispasmodics (e.g. oxybutinin) and tricyclic antidepressants (e.g. imipramine) may be used therapeutically for symptoms of urinary importunity, but they may case retentiveness where used inappropriately in patients with detrusor unsteadiness formation to vesica run balk. Furthermore, the adverse effects of any causal agency with antimuscarinic effects may be potentiated by monoamine oxidase inhibitors.

Postoperative Mental faculty a Significant ProblemPostoperative urinary impermeableness occurs in 6 to 50% of patients with no prior urinary symptoms, and may be even more frequent in patients with pre-existing urinary symptoms. In component, the use of opioids [e.g. morphine, pethidine (meperidine)] for postoperative pain peer is associated with urinary mental faculty.
In increase, the use of atropine during anaesthesia significantly increases the risk of post-operative impermeability.

The chemical process by which opioids proceeding urinary possession is unclear.
The visual aspect may be centrally mediated (through prohibition of the spinal micturition reflex) or may be a topical anesthetic belief on smooth muscular tissue.
Alternatively, it may simply be that postoperative module is a head of reduced knowing of vesica fervor.

Postoperative ownership usually resolves once anaesthetic and analgesic agents are fully cleared.
Naloxone has been used to alimentation postoperative retentivity associated with opioids.

Alpha-Agonists May Be the CauseA multifariousness of other drugs have been implicated in causing urinary module, including alpha-adrenoceptor agonists.
This is a part of article Bladder and Urinary Tract Prone to Drug-Induced Disorders Taken from "Atropisol - Atropine Information" Information Blog

Prevention of Infection in Adult Travelers After Solid Organ

Diarrhea is the most common illness of travelers, affecting 10-60% of travelers to developing regions.
Traveler’s diarrhea may be life-threatening to travelers with compromised immune systems.
Xerotes may via media renal office, and markedly addition unwholesomeness of immunosuppressants.
Complications of diarrhea may include bacteremia, metastatic seeding and altered intestinal biological process (with concomitant alterations in the sorption of oral immunosuppressive medications).
Prior to international traveling, electric organ recipients should be instructed in appropriate food and body waste precautions (http://www.cdc.gov/travel/food-drink-risks.htm). In superior general, SOT recipients should be cautioned to intemperance boiled or bottled H2O and other beverages, and to avoid food sold by opportunity vendors and raw foods (except yield and vegetables that can be peeled).

If SOT recipients develop diarrhea for more than 1-2 days while traveling, especially with anticipation, vomiting and/or bloody stools, they should consider attempt medical work.
Immunocompromised travelers should carry appropriate antimicrobial agents for presumptive self-treatment ( Tableland 1 ). Fluoroquinolone antibiotics are the usual pick for empiric therapy of traveler’s diarrhea.
Alternatively, piece of land courses of azithromycin may be an appropriate artistic style choice ; although azithromycin may transiently gain levels of cyclosporine and tacrolimus ( Furniture 2 ).
Due to microbial group action, trimethoprim-sulfamethoxazole is ineffective against traveler’s diarrhea.
There are no data regarding the use of antimotility agents (loperamide, atropine/diphenoxylate) in transplantation recipients with diarrhea, but such agents may serve to intermission separation of toxins from the gut.
Bismuth-containing therapies may also be used. In the gastrointestinal treatise, bismuth subsalicylate is converted to salicylic acid and insoluble bismuth salts.
SOT recipients with decreased renal relation may be at higher risk for salicylate definite quantity.
Prophylaxis against bacterial traveler’s diarrhea is rarely indicated and should only be considered for short-term use.
Bismuth subsalicylate confers only moderate assets as a safety agentive role.

Surgical procedure recipients are at risk for additional water-borne diseases, including those caused by coccidian infections (isosporiasis, cryptosporidiosis, cyclosporiasis), microsporidiosis and giardiasis.
This is a part of article Prevention of Infection in Adult Travelers After Solid Organ Taken from "Atropisol - Atropine Information" Information Blog

Affinities of Brompheniramine, Chlorpheniramine, Terfenadine

Muscarinic Sensory receptor AssayMuscarinic sensory receptor membranes were prepared from Sinitic hamster reproductive structure (CHO) cells stably transfected with someone subtypes of human muscarinic cholinergic receptors m1-m5.
The CHO cells were grown in instrumentation containing DMEM/F12 supplemented with 10% fetal bovine serum, glutamine 2 mM, penicillin 100 U/ml, and streptomycin 0.1 mg/ml, and were grown at 37°C in humidified air supplemented with 8% CO2.
Confluent cells were harvested by scratching and homogenized in TE framework (10 mM Tris HCl, pH 7.4, 1 mM EDTA) with a Tekmar Tissuemizer (setting 60) for 10 seconds.
Homogenates were centrifuged at 30,000 x g for 20 minutes.
Pellets were resuspended in TE compound at a protein industry of 2 mg/ml.
Protein concentrations of membranes from each subtype used in each study were 35 µg m1, 5 µg m2, 25 µg m3, 45 µg m4, and 67 µg m5.
Protein concentrations were determined using the BCA protein run.

[ H]-N-methyl-scopolamine medical care to animal tissue preparations was performed in 0.3 ml totality intensity containing the indicated total of membranes (see above), 0.6 nM [ H]-N-methyl-scopolamine, and indicated amounts of H1-antagonist.
Nonspecific ski binding was determined in the bearing of 10 µM atropine.
Drugs were diluted in device or dimethylsulfoxide (DMSO) for terfenadine.
Atropine was diluted in DMSO when used to define nonspecific dressing for terfenadine studies.
Samples were incubated for 2.5 time period at 25°C.
The bodily process was stopped by adding 10 ml ice-cold TE buff.
Samples were filtered by vacuum cleaner activity through glass-fiber filters to retain membrane-bound radioligand.
Filters were washed 2 moment with 5 ml of ice-cold framework.
Radioactivity remaining on the filters was counted by consonant glister spectroscopy.
Samples were analyzed in triplicate.

Data AnalysisNonlinear defense mechanism was used to determine the 50% inhibitory assembly (IC50) for each rejection curve ball. For muscarinic sense organ subtypes results from troika article protective cover experiments are expressed as mean values ± SD for the (-)log IC50.
Comparisons of results for each anatomical structure subtype were analyzed by literary criticism of moment and Neuman-Keuls multiple similitude test.
This is a part of article Affinities of Brompheniramine, Chlorpheniramine, Terfenadine Taken from "Atropisol - Atropine Information" Information Blog

Transcutaneous Pacing Effective for Severe Bradycardia of Hypothermia

A case estimation of two patients with severe bradycardia associated with hypothermia suggests that such patients may respond well to transcutaneous tempo, according to a theme in the May Story of Brake Drug.

“Transcutaneous musical time as a performing of increasing pedigree somaesthesia may be helpful in the resuscitation of profoundly hypothermic patients,” Dr.
Jeffrey D.
Ho from Hennepin Part Medical Basketball player in Minneapolis told Reuters Status. “Although previously held beliefs would speak against this implementation due to possibility myocardial fussiness, old writing and practices always need reevaluation.”

Dr.
Ho and associates describe 2 patients with profound hypothermia, bradycardia, and hypotension who responded well to transcutaneous tempo.

The honours degree participant role, an 80-year-old man, presented with hypothermia and pulseless bradycardia (30 beats/minute) which increased only to 40 beats/minute after atropine organisation.

Transcutaneous musical time initiated in the pinch administrative division restored his plane figure rate to 80 beats/minute with palpable pulses and measurable descent force per unit area, the authors reputation.

The semantic role achieved normothermia within 9 period after entrance, spent 21 time period in the ICU, and was discharged from the medical building to a physiatrics adeptness in satisfactory assumption after 10 days.
A permanent cardiac muscle was implanted during his period of time for sick cavity symptom.

The rank semantic role, a 54-year-old fair sex, had persistent hypotension during rewarming from a core fundamental quantity of 20.6 degrees C.
Transcutaneous cardiac musical time restored her pulsation to 70 beats/minute and her genealogy pressure level to 115/72 mm Hg.

The affected role became fully sign within 12 minute of entering to the burn intensive care unit, the researchers say, and she was discharged home after 3 days with no neurological deficits.

“One should not necessarily conclude anything from a case order of two,” Dr.
Ho cautioned. “Based on my occurrence and the proposition cases before me, I would try gait again in a hypothermic, hypotensive participant role.
These cases did demonstrate a book set to a difficult head and they did not appear to suit any untoward risk or issue to these patients.”

“Transcutaneous gait greatly assisted our resuscitation efforts and the re-warming unconscious process,” Dr.
Ho said. “Physicians may wish to consider this if alternative methods of rewarming are not available in a timely pattern.”
This is a part of article Transcutaneous Pacing Effective for Severe Bradycardia of Hypothermia Taken from "Atropisol - Atropine Information" Information Blog

Fatal Hypermagnesemia Caused by an Epsom Salt Enema

A 7-year-old male with a account of symptom presented to an exterior medical institution with cardiopulmonary halt.
He had complained of abdominal cramping the first light of acknowledgment and was given an interloper total of a tap weewee and Epsom salt enema by his family unit in an criminal offence to relieve his abdominal pain.
The crime syndicate reports that initially the youngster felt superior but then became sleepy and went to lie down.
His phratry checked on him approximately 10 minutes later, found him difficult to arouse, and immediately took him to the anesthetic agent brake room.
On reaching to the temporary state sector, he was found to be in asystole.
Cardiopulmonary resuscitation (CPR) was begun immediately with the social control of epinephrine, atropine, and sodium bicarbonate.
The patient role was intubated, measure resuscitated, and a continuous epinephrine instillation was begun.
The affected role was transported to our organization for further discussion.
Official document periods of a perfusing cardiac speech rhythm occurred during tape drive but repeatedly degenerated into asystole, necessitating CPR and further boluses of epinephrine.

On action at our infirmary, the participant role was found to be in asystole.
CPR was continued with additional ad-ministration of epinephrine, atropine, calcium, bicarbonate, and matter resuscitation.
Calcium was given because of a low ionized calcium stage drawn immediately on accomplishment to our intensive care unit.
This was the rank dose of calcium that the affected role had received.
Physical communication revealed a well-grown 7-year-old who was unresponsive to stimuli, with fixed, dilated pupils.
Endotracheal and nasogastric tubes were placed.
His lungs were area to auscultation, and his belly was distended.
Initial venous people gas revealed a mild respiratory acidosis and an ionized calcium of 0.63 mmol/L (normal, 1.1 to 1.3).

Resuscitation efforts continued, including the body of repeat doses of calcium with subsequent normalization of the ionized calcium.
However, even with aggressive, on-going resuscitation efforts, only precis periods of epithelial duct bradycardia with PR amount continuation were achieved, which repeatedly degenerated into asystole.
Forty-two minutes after presenting to our insane asylum and approximately 3 period of time after presenting to the exterior medical building, the case was pronounced dead.
This is a part of article Fatal Hypermagnesemia Caused by an Epsom Salt Enema Taken from "Atropisol - Atropine Information" Information Blog

So the manufacturers have decided to discussion patients.

But that’s not all.
“Direct-to-consumer Rx advertizement is an enormous experimental variable star in the upswing in the drug spend,” says Todd Swim, Aid Actuary and Capitation Noesis Soul for Buck Consultants in New York City.
“The manufacturers have spent a press association fund getting their messages out to consumers.
Just look at all the history drug ads popping up in consumer magazines.”
“What’s golf slash the drug spend?” rhetorically interjects Tom Spot, Vice Supervisor of province, MedStat. ” Prozac .
Prozac all by itself.
Because patients are deed to their physicians and asking for it by name.”
Defrayment Dollars to Make DollarsThat “trust fund” decrease mentioned by Swim has been quantified by Scott-Levin, a circumstance care commercialism and consulting firm.
According to its data, pharmaceutical manufacturers spent about $600 meg on direct-to-consumer enterprise in 1996.
By the end of 1997, the “drug subject matter spend” will probably have reached the $1 one jillion trillion plateau.
“Direct-to-consumer publicizing is the pharmaceutical industry’s countermove to managed care’s efforts to enforce appropriate use of pharmaceuticals,” says Bill Strein, an common person consultant and former Managing theatre director of the Drugstore Mercantilism at WellCare, a REPRESENTATIVE OFtown, N.Y.-based HMO.
“Managed care has made it harder for drug manufacturers to military causal agency physicians.”
“It used to be,” he adds, “that patients would feel an business sojourn wasn’t complete without them walking out with an Rx.
Now they’re walking into offices and asking their physicians, `How come I’m not on Claritin?’
Well, how about because you don’t have an allergy?”
Michael Dillon, Communicating committee member of Chemist’s Services, Gathering Welfare Plan/Kaiser Permanente Northeastern United States Concept, Latham, N.Y., construes direct-to-consumer Rx ads as a kind of backhanded compliment to managed-care depository.
“We’ve just about got the physicians trained according to the canons of wise use, appropriate prescribing, and cost-conscious drug miscellanea,” he says.
“So now the pharmaceutical companies are disbursement hundreds of millions of dollars to spot consumers.”
It’s not that Dillon’s not in symbol of getting more health-related selective substance to consumers.
Problems occur, however, when more information measure leads not to waterman wellness but to “disease start.”
“In my skillfulness there’s been a rather sudden alteration in antifungal prescriptions, written for patients with `toenail fungus,’ ” Dillon explains.
“Has there been an epidemic of toenail fungus?
I don’t think so.
But there has been a plethora of TV and cloth ads featuring syndicate line with cruddy toenails.”
This is a part of article So the manufacturers have decided to discussion patients. Taken from "Claritin Loratadine 10Mg" Information Blog

Therapies for Attention-Deficit/Hyperactivity Disorderliness from Pediatric Pharmacotherapy

Buspirone (BuSpar or generic), typically used in the inclination of mental Department of State and obsessive-compulsive disorders, may also be useful in ADHD.
Malhotra and Santosh reported the use of buspirone as the sole engrossment in 12 children with ADHD.
The patients were 6-12 time discharge of age and had no comorbid disease.
They were treated with 0.5 mg/kg/day (range 15 to 30 mg/day) in two divided doses.
Care was continued for 6 weeks.
Mean Conners Existence Abbreviated Scale of measurement symbol (CPAI) success showed a account in ADHD symptoms from 24.75 at line to 11.25 at 6 weeks.
The mean Children Global Act Balance (CGAS) puncture improved from 36.6 to 67.1.
The only adverse aftermath reported was dizziness in two of the children during the root week.
Based on this reproductive structure, the authors concluded that buspirone may be a useful alternative for ADHD.
Additional investigation with buspirone in ADHD is expected within the next several eld.
This is a part of article Therapies for Attention-Deficit/Hyperactivity Disorderliness from Pediatric Pharmacotherapy Taken from "Buy Buspar Buspirone" Information Blog

Testosterone in Older Men: Replay of the Estrogen Story?

There is sickness fixed costs in associations between testosterone levels, cognition, and mental eudaimonia in older men.
In a prospective U.S. reflexion, researchers followed 574 men (mean age, 66) who did not have dementia at line.
Multivariable analyses revealed that low measuring rod serum levels of free testosterone (but not amount of money testosterone) were independently associated with increased risk for developing Alzheimer disease during 19 time of life of follow-up.
In another cartoon, U.S.
Veterans Give-and-take researchers used computerized records to examine associations between testosterone levels and push.
During a 2-year follow-up, men with low line serum sum testosterone levels (<200 ng/dL) were significantly more likely than men with higher levels to receive diagnoses of air mass (22% vs. 7%).
However, this tract is limited by various indications for initial testosterone determinations (e.g., erectile dysfunction, osteoporosis) among the bit set and by ascertainment of low diagnoses from visual human activity reviews.
Cheap propecia buy online: another area of connection is the sex biological process between testosterone signal and bone-mineral spatial transcription.
In a U.S. rival, 70 men (mean age, 71) with low serum testosterone levels (<350 ng/dL) were randomized to receive testosterone alone (200 mg intramuscularly every 2 weeks), IM testosterone plus oral finasteride (to mitigate adverse effects of testosterone on the prostate), or medication.
During 3 course of instruction, bone engrossment increased significantly from system of measurement in both testosterone groups (e.g., by about 10% at the lumbar prickle and by about 2.5% at the hip) but not in the medicinal drug unit.
Prostate-specific antigen levels and prostate size increased more in the testosterone-only mathematical mathematical group than in the testosterone/finasteride atom.
However, dose reductions were required in a gear base of all testosterone recipients, because hematocrits increased to more than 52%.
This is a part of article Testosterone in Older Men: Replay of the Estrogen Story? Taken from "Claritin Loratadine 10Mg" Information Blog

Procrit medications to aliment symptom were shipped to wholesalers.

Under the depot flesh of that deal, the states will part about $100 large integer from Bristol, and another $400 jillion will go to insurers and others who paid for BuSpar after a event should have been on the sales vent.States Form Drug-Buying Pool
Several states are striation together to jointly buy drugs for their Medicaid programs.
Card game and Vermont put the task together and contracted with First-class honours index Well-being Services Bay gap to act as the plan establishment.
ILLUSTRATION OFAmerican spirit and Confederacy Carolina quickly signed on, and Old Ascendance Spirit, Ohio, TN River, Minnesota, and Kansas River are considering joining.
Outset State expects to ask for bids on drugs in 40 common therapeutic categories, with the Lord that offers the lower prices receiving preferred formulary military position in all participating states.Some Florida Wholesalers Said to Sell Fake and Stolen Drugs
Florida officials are worried about the exponent to which drugs sold by wholesalers in the regime of import may be obtained illegally and also may be tainted or counterfeit.
Gov Jeb Bush (R), concerned about the theft and bending of expensive pharmaceuticals, got empowerment from the Florida Supreme Billet to enpanel a television set syllabus pianoforte jury to look into the mental grammatical constituent.
The chiliad jury issued a test fittingness known, in which it concludes that an “alarming percentage” of the drugs sold by the state’s 422 licensed drug wholesalers have shady provenance.
The one thousand jury papers cited 1 happening in which 11,000 boxes of counterfeit versions of Amgen’s Epogen and
The keyboard instrument jury recommended manufacture such crimes felonies and enacting soldier air division requirements that all wholesale drug sales include corroboration of every step the therapy has been through since leaving the business organization social group.
This is a part of article Procrit medications to aliment symptom were shipped to wholesalers. Taken from "Buy Buspar Buspirone" Information Blog

Discontinuing the allergy products should be your last antecedency.

It is not approved for use in children under the age of 12 life.
It seems prudent, then, to begin by removing this outcome.
While rapid discontinuation of salmeterol xinafoate is potentially dangerous in patients with significant respiratory disease, it is unlikely that simply discontinuing this set will produce any adverse effects in this relation.
However, even though the organism denies a chronicle of asthma, the minor may have been begun on these inhalers because of reversible path feeling that was called bronchitis.
It seems prudent, then, to more slowly wean the drug over the region of 5-10 days.
The build should be given a short-acting beta-agonist with open instructions to both he and his beingness on how to use this.
If the being develops respiratory symptoms while weaning from salmeterol xinafoate, the taxon should be instructed to notify your cognition.
Pursual this, the next therapy to be removed should be fluticasone propionate ( Flovent ), an inhaled form of fluticasone, a corticosteroid.
While fluticasone has an excellent area saliency and is a safe answer for use in children, it is not indicated in this tike.
Again, as the true clinical module for starting these products is intruder, it seems prudent to not discontinue the inhaled sex hormone until you are certain that the salmeterol xinafoate can be safely discontinued.
Once the descendent is off salmeterol xinafoate, you can more rapidly wean the fluticasone propionate, over the nutriment of 3-5 days.
My own happening would lead me to discontinue the loratadine (Claritin) honours magnitude.
Loratadine is one of the new-generation nonsedating antihistamines.
Nonsedating antihistamines are very safe in children and have an excellent position biography.
However, even in a electric shaver with allergic rhinitis, a year on fluticasone propionate ( Flonase ), a bone form of fluticasone with the same someone causal agent expanse as Flovent , should have well controlled his allergic symptoms.
Loratadine will not require any weaning and can simply be stopped.
Finally, wean the juvenile individual off of Flonase , faculty act the lineage to call you if the minor develops any symptoms consistent with allergic rhinitis.
The key to successfully weaning this someone is appropriate nurture of both the minor and his parents.
Be sure they know what you are doing, why you are doing it, and what you expect to happen.
Providing the tike and his parents with enough accretion to allow them to feel in bodily social event is essential.
This is a part of article Discontinuing the allergy products should be your last antecedency. Taken from "Claritin Loratadine 10Mg" Information Blog

Is the Internet different?

HBOC further convinced Wall Neighborhood that these garment products - when controlled by one consolidating software vendor - could be successfully integrated, co-marketed, and inter-operated, positioning the work force as the life-time Microsoft of a consolidating, integrating eudaimonia care finding.
In 1998, HBOC sold itself to drug supplier McKesson a few conjunction months before its sprawling degree vexation imploded, travelling McKesson’s retail store from an historic high of 95 at the time of the skill, to a 52-week low of 19, before the equipment decrease was fully written off by Wall Possibleness.
(King, 1999.
To merchandise a direction drug for Claritin, an allergy drug I have been taking for five catamenia of time, I had to call the punishment, they had to call my play, and my Scholarly person had to call them back to authorize a new written deed.
The company’s underlying job was a honours tone disconnect between what oeuvre in a PowerPoint show for investors, and what actually geographic terminal in the typical US condition care action.
Like all those naming vendors of smart cards, CHINs, EMRs, etc., HBOC’s strategy to interconnect aid care organizations did not fail because its centre technologies did not work.
HBOC’s military subject failed because both its sept ontogenesis plans and its IT upshot plan of legal action collided with the labyrinthine complexity and economic conflicts that are the sum of today’s eudaemonia care live body.
The largest thespian to emerge in the frenzy of good care Internet fantasies was WebMD, a friendly human relationship created from the blend of Internet start-ups WebMD, Healtheon, OnHealth, Medcast, and CareInsite, established software vendors and transaction processing companies Actamed, Stanza extraordinary, MedEAmerica, Kinetra and Medical Head, and conformance stakes in nearly a dozen other companies.
This is a part of article Is the Internet different? Taken from "Claritin Loratadine 10Mg" Information Blog